Conference
BOLD-100-001 (TRIO039): A phase 1b dose-escalation study of BOLD-100 in combination with FOLFOX chemotherapy in patients with advanced gastrointestinal solid cancers: Interim safety, tolerability, and efficacy
Authors
Spratlin JL; Kane GO; Goodwin RA; McWhirter E; Thompson D; Halani K; Jones M; Snow M; McAllister ER; Machado A
Volume
40
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
June 1, 2022
Name of conference
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
ELECTR NETWORK
Conference start date
June 3, 2022
Conference end date
June 7, 2022
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
16
ISSN
0732-183X